MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Reductions in OFF time with ND0612 for patients with Parkinson’s disease experiencing motor fluctuations: Responder-analysis from an open-label Phase 2 study

    A. Ellenbogen, A. Espay, S. Isaacson, N. Lopes, N. Sasson, T. Yardeni, W. Poewe (Farmington Hills, USA)

    Objective: Evaluate the efficacy of subcutaneous levodopa/carbidopa infusion with investigational ND0612 in reducing OFF time in people with Parkinson’s disease (PwP) experiencing motor fluctuations. Background:…
  • 2023 International Congress

    Development of potent, orally bioavailable, and highly selective LRRK2 PROTAC® degrader molecules as potential disease modifying therapeutics for Parkinson’s disease

    K. Kelly, J. Meredith, L. Kimmel, S. Sparks, A. Desantis, D. Bryce, R. Wilson, J. Corradi, S. Keenan, G. Cadelina, J. Pizzano, A. Cacace (New Haven, USA)

    Objective: Report on the pharmacological characteristics of small molecule PROteolysis TArgeting Chimera (PROTAC) molecules designed to induce degradation of leucine rich repeat kinase 2 (LRRK2)…
  • 2023 International Congress

    Deep Brain Stimulation in Parkinson’s Disease: real-world outcomes at a single centre

    B. Lonergan, M. Ciocca, A. Bocum, D. Nandi, P. Bain, G. Charlesworth, N. Pavese, Y. Tai (London, United Kingdom)

    Objective: To describe the clinical outcomes in PD patients following DBS and analyse whether certain demographic and clinical factors are associated with poor outcomes. Background:…
  • 2023 International Congress

    Correlation between rem sleep disorders and neurocognitive defects in patients with parkinson´s disease

    M. Castillo, A. Mariñez, J. Duran, I. Joga, A. Morales (santo domingo, Dominican Republic)

    Objective: The objective of the following study was to verify the correlation between cognitive disordersand REM sleep disorders. Background: REM sleep disorder affect a large…
  • 2023 International Congress

    The effects of dopaminergic treatment on interhemispheric disinhibition and bradykinesia asymmetry in Parkinson’s disease

    M. de Riggi, G. Paparella, M. Bologna, D. Colella, A. Cannavacciuolo, A. de Biase, D. Birreci, D. Costa, A. Guerra, A. Berardelli (Rome, Italy)

    Objective: to investigate whether dopaminergic therapy modulates IHI and bradykinesia asymmetry in PD. Background: previous evidence demonstrated a reduced interhemispheric inhibition (IHI) in Parkinson’s disease…
  • 2023 International Congress

    Chronic sensorimotor cortex sensing using permanently implanted subgaleal leads in a patient receiving deep brain stimulation for Parkinson’s disease

    S. Sandoval-Pistorius, R. Fernandez-Gajardo, S. Cernera, P. Starr (San Francisco, USA)

    Objective: Assess the feasibility of chronic subgaleal cortical sensing using two distinct recording leads. Background: Pathological oscillatory activity in cortico-basal ganglia (BG) circuits is implicated…
  • 2023 International Congress

    Assessing Gait Disturbances in Parkinson’s Disease Using Multi-Spectral Diffusion Weighted Imaging

    I. Shelley, I. Ailes, M. Syed, K. Shivok, J. Miao, L. Krisa, F. Mohamed, R. Sergott, T. Liang, A. Sharan, M. Kogan, C. Wu, M. Alizadeh, O. Shoraka (Philadelphia, USA)

    Objective: We aimed to use diffusion MRI quantitative maps as an objective, non-invasive measure to assess for gait disturbances in Parkinson’s Disease (PD). Background: PD…
  • 2023 International Congress

    Gender inequities in people living with PD and their caregivers’ burden in Mexican population

    AJ. Hernández-Medrano, DP. Romero-Terán, MA. Ruiz-Mafud, MAG. Medrano-Delgado, MF. Medina-Pérez, AY. Regalado-Mustafá, DR. Aguila-Godinez, LG. Lira-Juarez, A. Domínguez-García, G. Hernández-Armesto, EC. Santiago-Delacruz, AA. Herrera-Ruiz, K. Talavera Lagunas, GI. Cerda-Hernández, A. Alcocer-Salas, JF. García-Hernández, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (La Fama, Tlalpan, Mexico)

    Objective: To compare motor and non-motor dysfunction, quality of life (QoL), and caregiver burden (CB) between women and men living with PD, and its relationship…
  • 2023 International Congress

    Combined approach in the diagnostic of Parkinson’s disease

    D D. Pokhabov, V. Abramov, T. Subbotina, D V. Pokhabov (Krasnoyarsk, Russian Federation)

    Objective: Our aim was to develop and scientifically substantiate set of criteria for early(preclinical) diagnosis of neurodegenerative disorders with the assessment of a number of…
  • 2023 International Congress

    A novel motor-learning based dysphagia treatment approach in Parkinson’s disease

    E. Wang, L. Verhagen Metman (Chicago, USA)

    Objective: This pilot study tested the effectiveness of a novel motor learning and exercise principle-based dysphagia treatment approach in PD. Background: Dysphagia occurs in 90% percent…
  • « Previous Page
  • 1
  • …
  • 257
  • 258
  • 259
  • 260
  • 261
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley